(Q35145627)

6 August 2017

1 reference

title

Costimulation of T cells by OX40, 4-1BB, and CD27. (English)

1 reference

6 August 2017

Michael Croft

1

1 reference

PubMed ID

12787564

6 August 2017

language of work or name

1 reference

1 June 2003

1 reference

Cytokine and Growth Factor Reviews

6 August 2017

1 reference

6 August 2017

14

1 reference

6 August 2017

265-273

1 reference

6 August 2017

3-4

1 reference

Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Presence of the T-cell activation marker OX-40 on tumor infiltrating lymphocytes and draining lymph node cells from patients with melanoma and head and neck cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

CD134/OX40 expression by synovial fluid CD4+ T lymphocytes in chronic synovitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

The expression of OX40 in immunologically mediated diseases of the gastrointestinal tract (celiac disease, Crohn's disease, ulcerative colitis)

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Expression of gp34 (OX40 ligand) and OX40 on human T cell clones

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Multiple levels of activation of murine CD8(+) intraepithelial lymphocytes defined by OX40 (CD134) expression: effects on cell-mediated cytotoxicity, IFN-gamma, and IL-10 regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

cDNA sequences of two inducible T-cell genes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Regulation of 4-1BB expression by cell-cell interactions and the cytokines, interleukin-2 and interleukin-4

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Co-stimulation of antigen-specific CD4 T cells by 4-1BB ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

The potential roles of 4-1BB costimulation in HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Cloning and expression of murine CD27: comparison with 4-1BB, another lymphocyte-specific member of the nerve growth factor receptor family.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

CD27/CD70 interaction directly drives B cell IgG and IgM synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Characterization of murine CD70 by molecular cloning and mAb.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5-positive CD4 cells and germinal centers.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

4-1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

In Vivo Triggering Through 4-1BB Enables Th-Independent Priming of CTL in the Presence of an Intact CD28 Costimulatory Pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

CD27 is required for generation and long-term maintenance of T cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Anti-tumor immunity elicited by a recombinant vaccinia virus expressing CD70 (CD27L).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

4-1BB co-stimulation enhances human CD8(+) T cell priming by augmenting the proliferation and survival of effector CD8(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Engagement of the OX-40 receptor in vivo enhances antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Defective T cell priming associated with aging can be rescued by signaling through 4-1BB (CD137).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Critical involvement of OX40 ligand signals in the T cell priming events during experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Human 4-1BB regulates CD28 co-stimulation to promote Th1 cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Antigen-presenting cell-derived signals determine expression levels of CD70 on primed T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

Phenotype and function of human B cells expressing CD70 (CD27 ligand)

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900025-X

7 January 2021

10.1016/S1359-6101(03)00025-X

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12787564